ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

8 links1 made here, not in the record14 judgments2 judges (the rules as one: Rule based)13 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05827081Phase IIIb Study ofRibociclib + ET in EarlyBreast CancerNovartis PharmaceuticalsPhase 3 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 9 · ClinicalTrials.gov record · Version of 2026-10-09Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Oct 16 · ClinicalTrials.gov record · Version of 2026-10-16Oct 19 · ClinicalTrials.gov record · Version of 2026-10-19Oct 23 · ClinicalTrials.gov record · Version of 2026-10-23Nov 3 · ClinicalTrials.gov record · Version of 2026-11-03Nov 10 · ClinicalTrials.gov record · Version of 2026-11-10Nov 13 · ClinicalTrials.gov record · Version of 2026-11-13Version of 2026-11-13CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedAs of now · Rule based · Main conditionMain conditionBreast Neoplasms, MaleThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSRibociclibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLetrozoleIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundGoserelinIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundLeuprolideIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundExemestaneIntervention entry›Nov 3 · Claude Opus 5.5 · Background · optionNov 18 · Rule based · BackgroundBackground · optionAnastrozoleMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · optionBackground · option

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Ribociclib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Ribociclib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 2The record itselfClinicalTrials.gov recordVersion of 2026-10-02Record change
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 9The record itselfClinicalTrials.gov recordVersion of 2026-10-09Record change
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Oct 16The record itselfClinicalTrials.gov recordVersion of 2026-10-16Record change
Oct 19The record itselfClinicalTrials.gov recordVersion of 2026-10-19Record change
Oct 23The record itselfClinicalTrials.gov recordVersion of 2026-10-23Record change
Nov 3RibociclibClaude Opus 5.5TestedCurrent
Nov 3LetrozoleClaude Opus 5.5BackgroundCurrent
Nov 3GoserelinClaude Opus 5.5BackgroundCurrent
Nov 3LeuprolideClaude Opus 5.5BackgroundCurrent
Nov 3ExemestaneClaude Opus 5.5Background · optionCurrent
Nov 3Anastrozolemade hereClaude Opus 5.5Background · optionCurrent
Nov 3The record itselfClinicalTrials.gov recordVersion of 2026-11-03Record change
Nov 10The record itselfClinicalTrials.gov recordVersion of 2026-11-10Record change
Nov 13The record itselfClinicalTrials.gov recordVersion of 2026-11-13Record change
Nov 14Breast NeoplasmsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Breast Neoplasms, MaleRule based · condition-kind ruleFinest filed termCurrent
Nov 18RibociclibRule based · role ruleTestedAgrees
Nov 18LetrozoleRule based · role ruleBackgroundAgrees
Nov 18GoserelinRule based · role ruleBackgroundAgrees
Nov 18LeuprolideRule based · role ruleBackgroundAgrees
Nov 18ExemestaneRule based · role ruleBackgroundAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.